Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT). The company along with ...
Tags: Alethia, US Patent, Cancer Treatment Methods